West Pharmaceutical Services
- Company Information
- Key Financials (last Fiscal Year)
- Profit Ratios
- Earnings Per Share (last Fiscal Year)
- Total Return
- Updated:6/3/26
- Country/Territory:U.S.
- Headquarters:Exton, Pa.
- Industry:Medical Products and Equipment
- CEO:Michel Lagarde
- Website:https://www.westpharma.com
- Ticker:WST
- Company type:Public
- Revenues ($M):$3,074
- Profits ($M):$494
- Market value ($M):$18,067
- Number of employees:10,800
Market value as of March 31, 2026.
- $ millions% change
- Revenues ($M):$3,074.16.3%
- Profits ($M):$493.70.2%
- Assets ($M):$4,270-
- Total Stockholder Equity ($M):$3,176-
- Profit as % of Revenues:16.1%
- Profits as % of Assets:11.6%
- Profits as % of Stockholder Equity:15.5%
- Earnings Per Share ($):6.80
- EPS % Change (from prior fiscal year):1.5%
- EPS % Change (5 year annual rate):8.2%
- EPS % Change (10 year annual rate):18%
- Total Return to Investors (last year):-15.7%
- Total Return to Investors (5 year, annualized):-0.3%
- Total Return to Investors (10 year, annualized):16.9%
West Pharmaceutical Services stock chart
West Pharmaceutical Services in Fortune Rankings